Title of article
Hematological Findings in COVID-19 and Insights to Stem Cell Therapy: From Bench to Practice
Author/Authors
Mohamed ، Sherif Ahmed Department of Chest Diseases and Tuberculosis - Faculty of Medicine - Assiut University , El- Gohary ، Ghada Departement of Adult Hematology/Internal Medicine - Ain Shams University , AlGahtani ، Farjah Department of Medicine, Division of Oncology/Hematology - College of Medicine - King Saud University , Alayoubi ، Fakher King Fahed Cardic Center, Medical College, College of Pharmacy - King Saud Univeraity , Abd El-Aziz ، Nashwa Department of Medical Oncology - South Egypt Cancer Institute - Assiut University
From page
1
To page
7
Abstract
Context: As the COVID-19 was spreading to all countries, its manifestations were identifying gradually, which were related to several organs. Evidence Acquisition: COVID-19 is associated with distinct hematological changes, increased serum inflammatory markers, and coagulopathy. Most of these changes are related to the patients’ prognosis and mortality, particularly in those with severe disease. Results: Firstly,wediscussed the associations between COVID-19 clinical featuresandcomplications, andsecondly, its hematological findings and coagulopathy are investigated. Conclusions: Such associations not only may shed light on our prognostic view of patients with COVID-19 but also will entail significant therapeutic implications. One of its key implications is to utilize the mesenchymal stem cells (MSCs) to treat patients with COVID-19. Herein, this kind of novel therapy will be discussed, as well.
Keywords
COVID , 19 , Hematological , Immunology , Lymphocytes Prognosis , Mesenchymal Stem Cells
Journal title
Journal of Skin and Stem Cell
Journal title
Journal of Skin and Stem Cell
Record number
2711917
Link To Document